e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD
E. Bargagli, (Siena, Italy), E. Renzoni (London, United Kingdom), O. Distler (Zurich, Switzerland), K. Antoniou (Heraklion, Greece), B. Crestani (Paris, France)
Source:
ERS webinar 2021: Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD
Number:
0
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bargagli, (Siena, Italy), E. Renzoni (London, United Kingdom), O. Distler (Zurich, Switzerland), K. Antoniou (Heraklion, Greece), B. Crestani (Paris, France). Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD. ERS webinar 2021: Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The new challenge of CTD-ILD: from basic science to clinical setting
Time to breathe: How COVID-19 interacts with interstitial lung disease
Debate – Controversies in interstitial lung disease
Related content which might interest you:
Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD?
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
ERS guidelines on treatment of sarcoidosis
Source: ERS webinar 2021: ERS guidelines on treatment of sarcoidosis
Year: 2021
Myositis-associated interstitial pneumonia (MaIP): Autoantibody associations in patients presenting to pulmonologists and rheumatologists
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Clinical study of pediatric interstitial lung diseases in China
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Pulmonary involvement in children with rheumatic diseases
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Clinical highlights from the 2011 ERS Congress in Amsterdam
Source: Eur Respir J 2012; 39: 1501-1510
Year: 2012
The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA)
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
The impact of definition of ILD on WHO group Classification of PH in scleroderma
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Respiratory function in systemic sclerosis patients
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations
Source: ERS webinar 2020: COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations
Year: 2020
COVID-19: Current Challenges in ILD
Source: ERS webinar 2020: COVID-19: Current Challenges in ILD
Year: 2020
The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001
An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013
What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Childhood interstitial lung disease: A diagnostic challenge
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept